サインイン

このコンテンツを視聴するには、JoVE 購読が必要です。 サインイン又は無料トライアルを申し込む。

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Pancreatic cancer remains one of the toughest cancers to treat. Therefore, it is critical that pre-clinical models evaluating treatment efficacy are reproducible and clinically relevant. This protocol describes a simple co-culture procedure to generate reproducible, clinically relevant desmoplastic spheroids.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers with a 5-year survival rate of <12%. The biggest barrier to therapy is the dense desmoplastic extracellular matrix (ECM) that surrounds the tumor and reduces vascularization, generally termed desmoplasia. A variety of drug combinations and formulations have been tested to treat the cancer, and although many of them show success pre-clinically, they fail clinically. It, therefore, becomes important to have a clinically relevant model available that can predict the response of the tumor to therapy. This model has been previously validated against resected clinical tumors. Here a simple protocol to grow desmoplastic three-dimensional (3D)-coculture spheroids is described that can naturally generating a robust ECM and do not require any external matrix sources or scaffold to support their growth.

Briefly human pancreatic stellate cells (HPaSteC) and PANC-1 cells are used to prepare a suspension containing the cells in a 1:2 ratio, respectively. The cells are plated in a poly-HEMA coated, 96-well low attachment U-well plate. The plate is centrifuged to allow the cells to form an initial pellet. The plate is stored in the incubator at 37 °C with 5% CO2, and media is replaced every 3 days. Plates can be imaged at designated intervals to measure spheroid volume. Following 14 days of culture, mature desmoplastic spheroids are formed (i.e. average volume of 0.048 + 0.012 mm3 (451 µm x 462.84 µm)) and can be utilized for experimental therapy assessment. Mature ECM components include collagen-I, hyaluronic acid, fibronectin, and laminin.

Introduction

Pancreatic cancer's poor prognosis is associated with a variety of reasons, among which is its lack of easily detectable biomarkers leading to a late detection. Another major reason is the thick stroma surrounding the tissue, which leads to reduced blood supply. The deposition of large amounts of extracellular matrix (ECM), cell-cell interaction, endothelial cells, various immune cells, pericytes, proliferating myofibroblast, and fibroblast population, and the presence of non-neoplastic cells (together constituting the desmoplastic reaction)1, constitute the thick stroma that is responsible for PDAC's chemo and radiotherapeutic resistan....

Protocol

1. 2D cell culture

  1. Grow PANC-1 cells in Dulbecco's Modified Eagle Medium (DMEM), supplemented with 10% fetal bovine serum (FBS) under sterile conditions. Grow up to 70%-80% confluency before passages, and do not use beyond the 20th passage. Refer to the process described in step 4.2.1.
    NOTE: As a reference point, 1 x 10cells in 20 mL of media need about 2-3 days to reach 70-80% confluency.
  2. Grow HPaSteC cells in stellate cell media supplemented.......

Representative Results

Three of the most critical steps involved in growing the spheroids are the initial cell count, the mixing steps while seeding the spheroids, and performing timely media changes to allow the spheroids to grow (Figure 1). Additionally, being familiar with Figure 2 on media changes after day 3 is critical to allow for effective media changes due to the increased media volume per well. When all these steps are performed according to the directi.......

Discussion

The duration and cell ratios chosen to grow the spheroids were based on studies as reported previously38. When attempting to optimize these studies by substituting NIH3T3 cells for HPaSteC cells, spheroid volumes and apoptosis patterns were found to closely resemble the reported optimized parameters (reported for PANC-1: NIH3T3:: 120:12) when PANC-1: HPaSteC ratios were at 120: 60. Although these studies only measure apoptosis until day 14, the protocol described in this process continues to use s.......

Acknowledgements

The work described was supported by the South Dakota Governors' Office of Economic Development, the South Dakota Board of Regents Competitive Research Grant Program (SD-BOR-CRGP), and the Department of Pharmaceutical Sciences at South Dakota State University for their support.

....

Materials

NameCompanyCatalog NumberComments
Axio Observer inverted microscopeCarl Zeiss0450-354
Cellometer Auto T4Nexcelom Bioscience LLCAuto-T4
DMEM, powder, high glucoseGibco12100046
Donkey anti-sheep conjugated with Alexa Fluor 568Abcamab175712
Fetal Bovine Serum CytivaSH3091003HI
Goat antirabbit IgG labeled with Alexa Fluor 488 Abcamab150077
Hanks Balanced Salt Solution (HBSS) Gibco14175145
Human Pancreatic Stellate Cells (HPaSteC)ScienCell3830
Microscope NikonNikonEclipse Ts 100
Nunc 96-Well Polystyrene Round Bottom Microwell PlatesThermo Scientific12-565-331
Olympus Fluoview FV1200 confocal laserOlympusN/ADiscontinued product
PANC-1ATCCCRL-1469
Poly-HEMASigmaP3932
Rabbit polyclonal anti-laminin antibodies Abcamab11575
Rabbit polyclonal anti-type I collagen antibodies Abcamab34710
Sheep polyclonal anti-hyaluronic acid antibodiesAbcamab53842
Stellate cell media complete kit ScienCell5301
Trypsin MP Biomedicals, LLC153571Trypsin solution prepared according to manufacturers protocol and used at 0.25%w/v 
Trypsin Neutralization Solution (TNS)ScienCell103

References

  1. Hingorani, S. R. Epithelial and stromal co-evolution and complicity in pancreatic cancer. Nat Rev Cancer. 23 (2), 57-77 (2023).
  2. Laklai, H., et al. Genotype tunes p....

Explore More Articles

Cancer Research

This article has been published

Video Coming Soon

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved